Journal of Experimental Medicine, Vol 171, 1943-1955, Copyright © 1990 by Rockefeller University Press

ARTICLES

Prevention and treatment of murine experimental allergic encephalomyelitis with T cell receptor V beta-specific antibodies

DM Zaller, G Osman, O Kanagawa and L Hood
Division of Biology, California Institute of Technology, Pasadena 91125.

Experimental allergic encephalomyelitis (EAE) is a model system for T cell-mediated autoimmune disease. Symptoms of EAE are similar to those of multiple sclerosis (MS) in humans. EAE is induced in susceptible animal strains by immunization with myelin basic protein (MBP) and potent adjuvant. The major T cell response to MBP in B10.PL mice is directed towards an NH2-terminal epitope and involves T cells expressing either V beta 8.2 or V beta 13 gene segments. Animals treated with a TCR V beta 8-specific mAb have a reduced incidence of EAE. We report here that the in vivo administration of a combination of anti-V beta 8.2 and anti-V beta 13 mAbs results in a long-term elimination of T cells involved in the response to MBP. When given before MBP immunization, anti-TCR antibody treatment leads to nearly complete protection against EAE. Antibody treatment also results in a dramatic reversal of paralysis in diseased animals. Thus, treatment with a combination of V beta-specific antibodies is a very effective therapy for the prevention and treatment of EAE. It is hoped that the future characterization of TCR V gene usage in human autoimmune diseases may lead to similar strategies of immune intervention.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Subramanian, S., Bourdette, D. N., Corless, C., Vandenbark, A. A., Offner, H., Jones, R. E. (2001). T Lymphocytes Promote the Development of Bone Marrow-Derived APC in the Central Nervous System. J. Immunol. 166: 370-376 [Abstract] [Full Text]  
• Namba, K., Ogasawara, K., Kitaichi, N., Morohashi, T., Sasamoto, Y., Kotake, S., Matsuda, H., Iwabuchi, K., Iwabuchi, C., Ohno, S., Onoe, K. (2000). Amelioration of Experimental Autoimmune Uveoretinitis by Pretreatment with a Pathogenic Peptide in Liposome and Anti-CD40 Ligand Monoclonal Antibody. J. Immunol. 165: 2962-2969 [Abstract] [Full Text]  
• Hanawa, H., Inomata, T., Okura, Y., Hirono, S., Ogawa, Y., Izumi, T., Kodama, M., Aizawa, Y. (1998). T Cells With Similar T-Cell Receptor ß-Chain Complementarity-Determining Region 3 Motifs Infiltrate Inflammatory Lesions of Synthetic Peptides Inducing Rat Autoimmune Myocarditis. Circ. Res. 83: 133-140 [Abstract] [Full Text]  
• Itoh, Y., Kajino, K., Ogasawara, K., Takahashi, A., Namba, K.-i., Negishi, I., Matsuki, N., Iwabuchi, K., Kakinuma, M., Good, R. A., Onoe, K. (1997). Interaction of pigeon cytochrome c-(43-58) peptide analogs with either T cell antigen receptor or I-Ab molecule. Proc. Natl. Acad. Sci. USA 94: 12047-12052 [Abstract] [Full Text]  
• Marusic, S., Tonegawa, S. (1997). Tolerance Induction and Autoimmune Encephalomyelitis Amelioration After Administration of Myelin Basic Protein-derived Peptide. J. Exp. Med. 186: 507-515 [Abstract] [Full Text]  
• Lanzavecchia, A (1993). Identifying strategies for immune intervention. Science 260: 937-944 [Abstract]  
• Gaur, A, Wiers, B, Liu, A, Rothbard, J, Fathman, C. (1992). Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. Science 258: 1491-1494 [Abstract]  
• Hugin, A., Vacchio, M., Morse, H. 3rd (1991). A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice. Science 252: 424-427 [Abstract]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS